efaproxiral has been researched along with Arteriosclerosis, Coronary in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bottomley, PA; Gerstenblith, G; Najjar, SS; Schulman, SP; Steffen, RP; Waldron, MM; Weiss, RG | 1 |
1 trial(s) available for efaproxiral and Arteriosclerosis, Coronary
| Article | Year |
|---|---|
Effects of a pharmacologically-induced shift of hemoglobin-oxygen dissociation on myocardial energetics during ischemia in patients with coronary artery disease.
Topics: Adenosine Triphosphate; Aged; Analysis of Variance; Aniline Compounds; Antisickling Agents; Biomarkers; Blood Flow Velocity; Coronary Artery Disease; Coronary Circulation; Cross-Over Studies; Double-Blind Method; Exercise Test; Female; Humans; Magnetic Resonance Spectroscopy; Male; Middle Aged; Myocardial Ischemia; Oxygen Consumption; Oxyhemoglobins; Phosphocreatine; Phosphorus Isotopes; Propionates; Treatment Outcome | 2005 |